Currently, there are 331.67M common shares owned by the public and among those 331.65M shares have been available to trade.
The company’s stock has a 5-day price change of 16.52% and 54.12% over the past three months. BILI shares are trading 90.71% year to date (YTD), with the 12-month market performance up to 93.42% higher. It has a 12-month low price of $8.80 and touched a high of $31.77 over the same period. BILI has an average intraday trading volume of 7.74 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 18.96%, 8.39%, and 45.80% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Bilibili Inc ADR (NASDAQ: BILI) shares accounts for 21.48% of the company’s 331.67M shares outstanding.
It has a market capitalization of $7.70B and a beta (3y monthly) value of 0.79. The earnings-per-share (ttm) stands at -$0.91. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.58% over the week and 3.58% over the month.
Analysts forecast that Bilibili Inc ADR (BILI) will achieve an EPS of 1.01 for the current quarter, 0.99 for the next quarter and 4.62 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.89 while analysts give the company a high EPS estimate of 0.89. Comparatively, EPS for the current quarter was -1.34 a year ago. Earnings per share for the fiscal year are expected to increase by 97.69%, and 2308.34% over the next financial year. EPS should grow at an annualized rate of 4.73% over the next five years, compared to -46.30% over the past 5-year period.
Goldman was of a view on September 26, 2024 that the stock is Buy, while Morgan Stanley gave the stock Equal-Weight rating on September 25, 2024, issuing a price target of $15- $20. Barclays on their part issued Overweight rating on August 23, 2024.
